PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 1 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $123,000 | +11.8% | 28,980 | 0.0% | 0.01% | -6.7% |
| Q1 2020 | $110,000 | -25.7% | 28,980 | 0.0% | 0.02% | -31.8% |
| Q4 2019 | $148,000 | +1.4% | 28,980 | 0.0% | 0.02% | -8.3% |
| Q3 2019 | $146,000 | -18.4% | 28,980 | 0.0% | 0.02% | -20.0% |
| Q2 2019 | $179,000 | +33.6% | 28,980 | 0.0% | 0.03% | +30.4% |
| Q1 2019 | $134,000 | – | 28,980 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|